A global biopharmaceutical company was preparing to launch a promising new rare disease therapy in the UK and Europe. Concerned that the company's functional leads were too busy managing existing products, senior leadership formed a global commercialization team to drive all launch activities. However, coordinating this cross-functional team—whose members included marketing, government affairs, manufacturing/supply, distribution, finance, IT, medical, and regulatory—was proving to be a challenge. The new product's therapeutic area lead turned to our team.
We connected the company with a senior life science strategist to help the company manage this critical work. He supported nine workstreams in total, managing deliverables, facilitating decisions with well-defined frameworks and templates, and acting as a strategic thought partner to team members within each function.
Related services & industries
Related Content
- Read More
Case Study
Accelerating Healthcare Innovation: A Strategic Approach to Market Entry
- Read More
Case Study
Digital Health Product Commercial Strategy
- Read More
Case Study
Commercial Quality Chat Bot Implementation
- Read More
Case Study
Clear definition of the project scope for the S4/HANA project
- Read More
Case Study
Etablierung von Cybersicherheitsfunktionen für führende CDMO
- Read More
Roundtable Digital
AI in Pharma: Transforming the Future of Sales Excellence and Operations
- Read More
Gender inclusivity in the pharmaceutical industry: An interview with Kanako Kikuchi, president of UCB Japan
Kanako Kikuchi, president of UCB Japan, discusses her career journey and offers advice to young female leaders on advancing their careers. - Read More
Leadership, breaking through, and the value of communications: An interview with Sally Susman, chief corporate affairs officer of Pfizer
Sally Susman shares her insights on what skills are most important as a leader, particularly a communications leader, as well as the value in humanity, humility, and humor. - Read More
Biotech focus: Finding CFOs for booming companies
For fast-growing biotech firms, CFOs with public company experience are increasingly important—and difficult to find. CEOs and boards who rethink where to find that expertise are more often finding the people they need, and finding them faster.
- Read More
Article
Route to the Top 2020: Interview with Jean-Christophe Tellier, CEO of UCB
Jean-Christophe Tellier, CEO of global biopharmaceutical company UCB, discusses the evolving role of the CEO, the impact of COVID-19 on the industry, and UCB’s sustainability agenda. - Read More
European pharma’s next chapter will be defined by execution
As AI, policy pressure, and patient expectations reshape European pharma, leaders will need to mobilize the right mix of governance, specialist expertise, and execution support fast to turn strategy into delivery. - Read More
Life sciences focus: Building a blended talent model for enterprise readiness
When a single regulatory event exposes quality and compliance risks across an entire global network, an organization must mobilize the right mix of leadership, execution, and expertise fast.
- Read More
MedTech focus: The rise of the strategy & corporate development function
MedTech companies are increasingly embracing the strategy or corporate development chief role. Insights from companies that have found leaders for this critical function offer a blueprint for recruiting this talent. - Read More
New leadership needs in biopharma: The connecting leader
As open innovation transforms the sector, biopharma companies need leaders who can enable effective collaboration, knowledge-sharing, and the integration of external and internal resources. - Read More
Becoming purposeful and performance-driven: A conversation with Jean-Luc Fleurial, EVP and CHRO of UCB
Jean-Luc Fleurial, CHRO of a global pharma company, shares how to become a more effective CHRO and build a purposeful, performance-driven culture.
- Read More
How to drive agile AI adoption: A conversation with Michael Lefenfeld, president and CEO of Hexion
Michael Lefenfeld shares how organizations can build AI-enabled workforces and strengthen leadership through consistent processes. - Read More
The generics mindset: A conversation with Richard Saynor, CEO of Sandoz
Richard Saynor reflects on what it takes for leaders to combine accountability, clear decision-making, and the humility to change course. - Read More
Growth, purpose, and people: A conversation with Dave Wessinger, co-founder and CEO of PointClickCare
Dave Wessinger reflects on scaling globally, balancing purpose with performance, and leading through growth and transformation.
- Read More
Empowering talent and navigating change: A conversation with Dr. Jerh Collins, chief technical operations and quality officer at Moderna
Dr. Jerh Collins shares leadership lessons on talent, resilience, and driving innovation in the fast-evolving biopharma sector. - Read More
Supply-chain officer focus: The strategic value of succession planning
Many organizations where the supply chain is crucial to operations have been elevating the strategic importance of their chief supply chain officers. But talent is scarce, and succession planning is taking on new urgency. Interviews with 30 supply chain leaders suggest three key elements of improvement.
Let's move forward
Tell us what you're facing. We’ll work alongside you to define the next step.